Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Board of Directors authorizes new 1billionsharerepurchaseprogramWAYNE,Pa.,Dec.09,2025(GLOBENEWSWIRE)TeleflexIncorporated(NYSE:TFX),aleadingglobalproviderofmedicaltechnologies,todayannouncedithasenteredintodefinitiveagreementstosellthecompanysAcuteCare,InterventionalUrologyandOEMbusinessestotwobuyers,Intersurgical®LtdwithrespecttoAcuteCareandInterventionalUrology,andMontaguandKohlbergwithrespecttoOEM,foracombinedtotalof1 billion share repurchase programWAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the company’s Acute Care, Interventional Urology and OEM businesses to two buyers, Intersurgical® Ltd with respect to Acute Care and Interventional Urology, and Montagu and Kohlberg with respect to OEM, for a combined total of 2.03 billion in ca ...